| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | HULC complex | 1.02e-04 | 4 | 87 | 2 | GO:0033503 | |
| Domain | BAF250_C | 2.05e-05 | 2 | 85 | 2 | IPR033388 | |
| Domain | BAF250_C | 2.05e-05 | 2 | 85 | 2 | PF12031 | |
| Domain | BAF250/Osa | 2.05e-05 | 2 | 85 | 2 | IPR021906 | |
| Domain | Cadherin_CS | 1.40e-04 | 109 | 85 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 1.66e-04 | 113 | 85 | 5 | PS00232 | |
| Domain | Cadherin | 1.66e-04 | 113 | 85 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.72e-04 | 114 | 85 | 5 | PS50268 | |
| Domain | - | 1.72e-04 | 114 | 85 | 5 | 2.60.40.60 | |
| Domain | CA | 1.80e-04 | 115 | 85 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.87e-04 | 116 | 85 | 5 | IPR015919 | |
| Domain | Cadherin | 2.03e-04 | 118 | 85 | 5 | IPR002126 | |
| Domain | Cadherin_2 | 2.19e-04 | 65 | 85 | 4 | PF08266 | |
| Domain | Cadherin_N | 2.19e-04 | 65 | 85 | 4 | IPR013164 | |
| Domain | Cadherin_tail | 6.32e-04 | 37 | 85 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 6.32e-04 | 37 | 85 | 3 | IPR031904 | |
| Domain | SAM/pointed | 2.00e-03 | 117 | 85 | 4 | IPR013761 | |
| Domain | - | 2.07e-03 | 15 | 85 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 2.07e-03 | 15 | 85 | 2 | SM00501 | |
| Domain | ARID_dom | 2.07e-03 | 15 | 85 | 2 | IPR001606 | |
| Domain | ARID | 2.07e-03 | 15 | 85 | 2 | PS51011 | |
| Domain | ARID | 2.07e-03 | 15 | 85 | 2 | PF01388 | |
| Domain | Znf_ZZ | 3.33e-03 | 19 | 85 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 3.33e-03 | 19 | 85 | 2 | SM00291 | |
| Domain | Znf_C2H2_jaz | 4.46e-03 | 22 | 85 | 2 | IPR022755 | |
| Domain | zf-C2H2_jaz | 4.46e-03 | 22 | 85 | 2 | PF12171 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP350 KIAA1671 MAGI1 HIVEP2 NF1 DSG2 MYCBP2 SAMD11 PLEKHG3 PATZ1 PPFIBP1 MAP4K1 COBLL1 MCCC1 KIAA1191 NCKAP5L PABIR2 CEP170B ITPKB | 3.57e-13 | 861 | 87 | 19 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D16 HIVEP3 HIVEP2 SETD1B RARG WIZ MYCBP2 CTC1 KIF26A ZNF398 RNF40 ARID1A LARS2 MED13 CEP170B PRRC2B MAP3K5 | 1.85e-09 | 1105 | 87 | 17 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | KIAA1671 BPTF ARID1B HIVEP2 ZZZ3 WIZ TADA2A ARID1A MGA PRRC2B | 1.94e-08 | 351 | 87 | 10 | 38297188 |
| Pubmed | KIAA1671 ZZZ3 WIZ KIF15 MYCBP2 RNF40 TADA2A MCCC1 MGA L3MBTL3 | 9.92e-08 | 418 | 87 | 10 | 34709266 | |
| Pubmed | KIAA1671 BPTF ZNF469 ARID1B ZZZ3 ATXN7L2 WIZ DSG2 PATZ1 TADA2A ARID1A NCKAP5L MGA CEP170B PRRC2B | 1.09e-07 | 1116 | 87 | 15 | 31753913 | |
| Pubmed | KIAA1671 BPTF ARID1B ZZZ3 WIZ DSG2 MYCBP2 ARID1A GPRIN1 MGA PRRC2B | 1.30e-07 | 549 | 87 | 11 | 38280479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIAA1671 ZZZ3 SETD1B KIF15 RNF40 MCCC1 BSN ARID1A NCKAP5L CEP170B PRRC2B | 2.58e-07 | 588 | 87 | 11 | 38580884 |
| Pubmed | 2.71e-07 | 105 | 87 | 6 | 9628581 | ||
| Pubmed | CEP350 KIAA1671 ARID1B WIZ KIF15 MYCBP2 KCNMA1 ARID1A GPRIN1 NCKAP5L L3MBTL3 PABIR2 PRRC2B EHD4 | 3.30e-07 | 1049 | 87 | 14 | 27880917 | |
| Pubmed | 3.87e-07 | 268 | 87 | 8 | 33640491 | ||
| Pubmed | 5.25e-07 | 7 | 87 | 3 | 30649429 | ||
| Pubmed | MAGI1 NF1 WIZ KIF15 DSCAM MYCBP2 PATZ1 KCNMA1 BSN MGA CEP170B PRRC2B MAP3K5 | 8.00e-07 | 963 | 87 | 13 | 28671696 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.64e-06 | 440 | 87 | 9 | 34244565 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 3.12e-06 | 40 | 87 | 4 | 34585037 | |
| Pubmed | CEP350 MAGI1 HIVEP2 KIF26A COBLL1 NCKAP5L MGA CCDC88B MAP3K5 | 3.69e-06 | 486 | 87 | 9 | 20936779 | |
| Pubmed | CEP350 KIAA1671 NEO1 WIZ DSCAM DSG2 PPFIBP1 MCCC1 GPRIN1 MGA PRRC2B | 3.86e-06 | 777 | 87 | 11 | 35844135 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BPTF ZZZ3 SRSF2 ATXN7L2 WIZ PATZ1 RNF20 RNF40 TADA2A MCCC1 GPATCH8 ARID1A MGA L3MBTL3 | 3.89e-06 | 1294 | 87 | 14 | 30804502 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 4.10e-06 | 167 | 87 | 6 | 20362541 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 4.28e-06 | 495 | 87 | 9 | 27705803 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34386776 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 23202128 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22354749 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 25788518 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 33890484 | ||
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 6.19e-06 | 2 | 87 | 2 | 24562383 | |
| Pubmed | Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state. | 6.19e-06 | 2 | 87 | 2 | 23869022 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 37422774 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20404140 | ||
| Pubmed | MAGI-1 interacts with Slo1 channel proteins and suppresses Slo1 expression on the cell surface. | 6.19e-06 | 2 | 87 | 2 | 19403801 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 6.19e-06 | 2 | 87 | 2 | 37611161 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 32791957 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 6.19e-06 | 2 | 87 | 2 | 29890703 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 30692271 | ||
| Pubmed | RNF20 and RNF40 regulate vitamin D receptor-dependent signaling in inflammatory bowel disease. | 6.19e-06 | 2 | 87 | 2 | 34088983 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24788099 | ||
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 6.19e-06 | 2 | 87 | 2 | 28967863 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 33052929 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 38081808 | ||
| Pubmed | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties. | 6.19e-06 | 2 | 87 | 2 | 2247438 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 20738173 | ||
| Pubmed | Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas. | 6.19e-06 | 2 | 87 | 2 | 27562491 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 34290256 | ||
| Pubmed | 6.73e-06 | 15 | 87 | 3 | 15640798 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 KIAA1671 BPTF NF1 SRSF2 DSG2 MYCBP2 PLEKHG3 APMAP EMG1 MGA EHD4 | 9.28e-06 | 1024 | 87 | 12 | 24711643 |
| Pubmed | 1.00e-05 | 17 | 87 | 3 | 29911975 | ||
| Pubmed | TBC1D16 NF1 DSG2 MYCBP2 SAMD11 PLEKHG3 GPATCH8 KIAA1191 NCKAP5L PABIR2 MED13 CEP170B PRRC2B | 1.01e-05 | 1215 | 87 | 13 | 15146197 | |
| Pubmed | KIAA1671 BPTF ARID1B ZZZ3 ATXN7L2 WIZ SAMD11 TADA2A MCCC1 GPATCH8 ARID1A MGA L3MBTL3 PRRC2B | 1.20e-05 | 1429 | 87 | 14 | 35140242 | |
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 1.20e-05 | 18 | 87 | 3 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 1.20e-05 | 18 | 87 | 3 | 10662547 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.30e-05 | 57 | 87 | 4 | 32633719 | |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 1.40e-05 | 58 | 87 | 4 | 30377227 | |
| Pubmed | 1.66e-05 | 446 | 87 | 8 | 24255178 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 33432679 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 21647563 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 22021426 | ||
| Pubmed | RNF20-RNF40: A ubiquitin-driven link between gene expression and the DNA damage response. | 1.85e-05 | 3 | 87 | 2 | 21827756 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 34044070 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.85e-05 | 3 | 87 | 2 | 26716708 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 27798111 | ||
| Pubmed | Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth. | 1.85e-05 | 3 | 87 | 2 | 22155569 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 9822156 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 20356838 | ||
| Pubmed | Dampening of death pathways by schnurri-2 is essential for T-cell development. | 1.85e-05 | 3 | 87 | 2 | 21475200 | |
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 1.85e-05 | 3 | 87 | 2 | 22426308 | |
| Pubmed | Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis. | 1.85e-05 | 3 | 87 | 2 | 22945628 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 24382590 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 34512623 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 2.26e-05 | 134 | 87 | 5 | 25452129 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BPTF NF1 SRSF2 MYCBP2 MAP4K1 RNF20 GPATCH8 HSF1 GPRIN1 MED13 | 2.40e-05 | 774 | 87 | 10 | 15302935 |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.63e-05 | 68 | 87 | 4 | 11230163 | |
| Pubmed | 2.73e-05 | 347 | 87 | 7 | 17114649 | ||
| Pubmed | 2.95e-05 | 24 | 87 | 3 | 24698270 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 3.30e-05 | 72 | 87 | 4 | 10380929 | |
| Pubmed | 3.36e-05 | 242 | 87 | 6 | 34011540 | ||
| Pubmed | 3.38e-05 | 493 | 87 | 8 | 15368895 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.41e-05 | 146 | 87 | 5 | 23892456 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.68e-05 | 74 | 87 | 4 | 10817752 | |
| Pubmed | Fbxl19 recruitment to CpG islands is required for Rnf20-mediated H2B mono-ubiquitination. | 3.70e-05 | 4 | 87 | 2 | 28453857 | |
| Pubmed | TRAIP/RNF206 is required for recruitment of RAP80 to sites of DNA damage. | 3.70e-05 | 4 | 87 | 2 | 26781088 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 21362549 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 38517892 | ||
| Pubmed | Egr2-guided histone H2B monoubiquitination is required for peripheral nervous system myelination. | 3.70e-05 | 4 | 87 | 2 | 32672815 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 24441044 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 33868474 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 3.70e-05 | 4 | 87 | 2 | 15170388 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 3.70e-05 | 4 | 87 | 2 | 11988099 | |
| Pubmed | 4.30e-05 | 77 | 87 | 4 | 10835267 | ||
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 4.73e-05 | 28 | 87 | 3 | 15347688 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.00e-05 | 80 | 87 | 4 | 10716726 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CEP350 KIAA1671 DSG2 PPFIBP1 MCCC1 KIAA1191 NCKAP5L MGA CEP170B PRRC2B | 5.44e-05 | 853 | 87 | 10 | 28718761 |
| Pubmed | 5.77e-05 | 83 | 87 | 4 | 28794006 | ||
| Pubmed | 5.85e-05 | 30 | 87 | 3 | 32562661 | ||
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 6.16e-05 | 5 | 87 | 2 | 12672490 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 12200431 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 10523862 | ||
| Pubmed | WAC, a functional partner of RNF20/40, regulates histone H2B ubiquitination and gene transcription. | 6.16e-05 | 5 | 87 | 2 | 21329877 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 38489371 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 37108169 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIAA1671 HIVEP3 MAGI1 BPTF HIVEP2 MYCBP2 PLEKHG3 APMAP KCNMA1 ARID1A CEP170B PCDHB16 ITPKB | 8.25e-05 | 1489 | 87 | 13 | 28611215 |
| Interaction | YWHAQ interactions | CEP350 KIAA1671 TH HIVEP2 NF1 DSG2 MYCBP2 SAMD11 PLEKHG3 PPFIBP1 COBLL1 RNF20 KCNMA1 MCCC1 HSF1 LARS2 NCKAP5L PABIR2 CEP170B MAP3K5 | 2.87e-08 | 1118 | 85 | 20 | int:YWHAQ |
| Interaction | EGR2 interactions | 6.30e-07 | 171 | 85 | 8 | int:EGR2 | |
| Interaction | SFN interactions | CEP350 KIAA1671 MAGI1 SRSF2 DSG2 MYCBP2 PLEKHG3 PPFIBP1 APMAP COBLL1 NCKAP5L PABIR2 CEP170B MAP3K5 | 1.11e-06 | 692 | 85 | 14 | int:SFN |
| Interaction | WWTR1 interactions | KIAA1671 BPTF ARID1B ZZZ3 WIZ DSG2 MYCBP2 ABT1 ARID1A GPRIN1 PRRC2B | 1.58e-06 | 422 | 85 | 11 | int:WWTR1 |
| Interaction | KDM1A interactions | CEP350 KIAA1671 C4orf17 ZZZ3 WIZ KIF15 MYCBP2 PLEKHG3 GSTCD RNF40 TADA2A MCCC1 HSF1 MGA L3MBTL3 ECE2 | 1.71e-06 | 941 | 85 | 16 | int:KDM1A |
| Interaction | PHF21A interactions | KIAA1671 ZZZ3 KIF15 MYCBP2 RNF40 TADA2A MCCC1 NCKAP5L MGA L3MBTL3 | 1.81e-06 | 343 | 85 | 10 | int:PHF21A |
| Interaction | YWHAH interactions | CEP350 KIAA1671 MAGI1 HIVEP2 NF1 DSG2 MYCBP2 SAMD11 PLEKHG3 PPFIBP1 COBLL1 KCNMA1 KIAA1191 NCKAP5L PABIR2 CEP170B MAP3K5 | 2.89e-06 | 1102 | 85 | 17 | int:YWHAH |
| Interaction | YWHAG interactions | CEP350 KIAA1671 MAGI1 HIVEP2 NF1 KIF15 DSG2 MYCBP2 SAMD11 PLEKHG3 PPFIBP1 COBLL1 KCNMA1 NCKAP5L PABIR2 CEP170B MAP3K5 ITPKB | 3.62e-06 | 1248 | 85 | 18 | int:YWHAG |
| Interaction | YWHAB interactions | CEP350 KIAA1671 MAGI1 TH NF1 DSG2 MYCBP2 PLEKHG3 PPFIBP1 COBLL1 KCNMA1 NCKAP5L PABIR2 CEP170B MAP3K5 ITPKB | 4.46e-06 | 1014 | 85 | 16 | int:YWHAB |
| Interaction | CDH19 interactions | 7.43e-06 | 30 | 85 | 4 | int:CDH19 | |
| Interaction | SIRT6 interactions | ARID1B NF1 SETD1B WIZ MYCBP2 SAMD11 PATZ1 RNF20 ABT1 RNF40 GPATCH8 ARID1A | 1.24e-05 | 628 | 85 | 12 | int:SIRT6 |
| Interaction | HNF4A interactions | 2.11e-05 | 275 | 85 | 8 | int:HNF4A | |
| Interaction | FEV interactions | 2.41e-05 | 203 | 85 | 7 | int:FEV | |
| Interaction | YWHAZ interactions | KIAA1671 TH HIVEP2 NF1 KIF15 DSG2 MYCBP2 PLEKHG3 PPFIBP1 COBLL1 KCNMA1 HSF1 ARID1A NCKAP5L PABIR2 CEP170B MAP3K5 | 3.05e-05 | 1319 | 85 | 17 | int:YWHAZ |
| Interaction | RCOR1 interactions | ZZZ3 MYCBP2 FAM169A RNF40 TADA2A MCCC1 NCKAP5L MGA L3MBTL3 ECE2 | 4.32e-05 | 494 | 85 | 10 | int:RCOR1 |
| Interaction | NFIX interactions | 4.91e-05 | 227 | 85 | 7 | int:NFIX | |
| Interaction | KLF3 interactions | 5.05e-05 | 228 | 85 | 7 | int:KLF3 | |
| Interaction | CLEC11A interactions | 5.36e-05 | 96 | 85 | 5 | int:CLEC11A | |
| Interaction | TFCP2L1 interactions | 6.21e-05 | 99 | 85 | 5 | int:TFCP2L1 | |
| Interaction | YWHAE interactions | KIAA1671 HIVEP2 NF1 SRSF2 MYCBP2 SAMD11 PLEKHG3 PPFIBP1 COBLL1 KCNMA1 HSF1 NCKAP5L MGA PABIR2 CEP170B MAP3K5 | 6.23e-05 | 1256 | 85 | 16 | int:YWHAE |
| Interaction | TEAD1 interactions | 1.01e-04 | 176 | 85 | 6 | int:TEAD1 | |
| Interaction | TOP3B interactions | TBC1D16 HIVEP3 HIVEP2 SETD1B RARG WIZ MYCBP2 CTC1 KIF26A ZNF398 RNF40 ARID1A LARS2 MED13 CEP170B PRRC2B MAP3K5 | 1.17e-04 | 1470 | 85 | 17 | int:TOP3B |
| Interaction | SUPT3H interactions | 1.28e-04 | 61 | 85 | 4 | int:SUPT3H | |
| Interaction | HNF1B interactions | 1.53e-04 | 190 | 85 | 6 | int:HNF1B | |
| Interaction | PAX6 interactions | 1.56e-04 | 366 | 85 | 8 | int:PAX6 | |
| Interaction | MYOD1 interactions | 1.71e-04 | 194 | 85 | 6 | int:MYOD1 | |
| Interaction | PI4KAP2 interactions | 1.74e-04 | 5 | 85 | 2 | int:PI4KAP2 | |
| Interaction | HSPB2 interactions | 2.02e-04 | 200 | 85 | 6 | int:HSPB2 | |
| Interaction | HDAC1 interactions | KIAA1671 BPTF ZZZ3 WIZ KIF15 MYCBP2 RNF20 RNF40 TADA2A MCCC1 HSF1 ARID1A MGA L3MBTL3 | 2.08e-04 | 1108 | 85 | 14 | int:HDAC1 |
| Interaction | C1QTNF4 interactions | 2.61e-04 | 6 | 85 | 2 | int:C1QTNF4 | |
| Interaction | NFIC interactions | 2.63e-04 | 210 | 85 | 6 | int:NFIC | |
| Interaction | SCRN2 interactions | 2.99e-04 | 31 | 85 | 3 | int:SCRN2 | |
| Cytoband | 5q31 | 7.08e-05 | 115 | 87 | 4 | 5q31 | |
| GeneFamily | Clustered protocadherins | 4.90e-05 | 64 | 57 | 4 | 20 | |
| GeneFamily | ATAC complex | 7.45e-04 | 13 | 57 | 2 | 1058 | |
| GeneFamily | AT-rich interaction domain containing | 9.99e-04 | 15 | 57 | 2 | 418 | |
| GeneFamily | Sterile alpha motif domain containing | 2.70e-03 | 88 | 57 | 3 | 760 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.60e-07 | 161 | 87 | 6 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.76e-06 | 186 | 87 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.76e-06 | 186 | 87 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.18e-06 | 193 | 87 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 196 | 87 | 6 | 22fcfb713f402ebbd43b2822f0fd919cdbfba6e4 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.53e-06 | 198 | 87 | 6 | f701d06e3d7fd2192afae3698c5ec3c355e96da3 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.76e-05 | 164 | 87 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 172 | 87 | 5 | 9dca1542145d88559527db7e0f6ad150df59ca2d | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 174 | 87 | 5 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 176 | 87 | 5 | 29cda51a99100ddd2928cadc92da40f001d7e1f4 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 176 | 87 | 5 | 01774a86d7d92f31a056b753f9844f923038003e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 182 | 87 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 91 | 87 | 4 | 25197fde8b9bdaf1e28add695d13aff3ff52d86e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-OPC_related-Oligodendrocyte/OPC|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.07e-05 | 91 | 87 | 4 | ed4a48e5e5f5d8aadbc7b1b8d84a5f6363a08b85 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 3.13e-05 | 185 | 87 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 187 | 87 | 5 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.38e-05 | 188 | 87 | 5 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.47e-05 | 189 | 87 | 5 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 192 | 87 | 5 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.74e-05 | 192 | 87 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.74e-05 | 192 | 87 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-05 | 192 | 87 | 5 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.83e-05 | 193 | 87 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.83e-05 | 193 | 87 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.93e-05 | 194 | 87 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 194 | 87 | 5 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.93e-05 | 194 | 87 | 5 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 196 | 87 | 5 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 196 | 87 | 5 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | distal-Epithelial-Club-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.33e-05 | 198 | 87 | 5 | 77c7fa7626ea35cb50de9c2f2df637d22e77d3fe | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 199 | 87 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-05 | 200 | 87 | 5 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-05 | 200 | 87 | 5 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-05 | 200 | 87 | 5 | 69707f9576d326a06faac49701ef5cd632e760f6 | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.54e-05 | 200 | 87 | 5 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuroepithelial-Proteoglycan-expressing_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-05 | 200 | 87 | 5 | f94381d0a3b5b81cdbb13b75fc0e4910cbd70382 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 200 | 87 | 5 | 90061284a80d29a4ca6078f578e13d32b8cc80e1 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 151 | 87 | 4 | a7b1a60d68f0ed17022fe4c97af64f9f08d39fa3 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 155 | 87 | 4 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-04 | 158 | 87 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.66e-04 | 159 | 87 | 4 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.66e-04 | 159 | 87 | 4 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.66e-04 | 159 | 87 | 4 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | Bronchial_Biopsy-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.86e-04 | 162 | 87 | 4 | 985adca17b0c99563feef7910f3da5df31e636b6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-04 | 162 | 87 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 2.92e-04 | 163 | 87 | 4 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 164 | 87 | 4 | d8ecb3de6e34f5f574449e3d2f26fa0b2b7e84e8 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-04 | 164 | 87 | 4 | 4ade97931ae1780af7836d988fe117a10b3e88a1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.06e-04 | 165 | 87 | 4 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.13e-04 | 166 | 87 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.20e-04 | 68 | 87 | 3 | cdb805182f7169fbc3bec31adec3a4e088281757 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 167 | 87 | 4 | 7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-04 | 168 | 87 | 4 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-04 | 171 | 87 | 4 | 845f312f8cbe29d820da25f0e6d75deb382bbfd8 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 171 | 87 | 4 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-04 | 171 | 87 | 4 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-04 | 172 | 87 | 4 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-04 | 172 | 87 | 4 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-04 | 172 | 87 | 4 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.66e-04 | 173 | 87 | 4 | 1bf9c91c1803a540b5e43bc4280aab4289341cee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 173 | 87 | 4 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 173 | 87 | 4 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.83e-04 | 175 | 87 | 4 | 282f09bbdfa70d93b3f66591dcfb84c5ee0268c7 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-04 | 176 | 87 | 4 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.91e-04 | 176 | 87 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 176 | 87 | 4 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.91e-04 | 176 | 87 | 4 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-04 | 176 | 87 | 4 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 3.91e-04 | 176 | 87 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.91e-04 | 176 | 87 | 4 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 176 | 87 | 4 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.91e-04 | 176 | 87 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.00e-04 | 177 | 87 | 4 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 177 | 87 | 4 | 9b02fd91c110b405eba6cb74ceb90b1286535973 | |
| ToppCell | Control-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 4.00e-04 | 177 | 87 | 4 | e82115bfc32c7b689460fbc5caeb983c1aabe30f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-04 | 178 | 87 | 4 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.17e-04 | 179 | 87 | 4 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-04 | 181 | 87 | 4 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.35e-04 | 181 | 87 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Influenza_Severe-B_naive|World / Disease group and Cell class | 4.44e-04 | 182 | 87 | 4 | e4885a5e6065c9c403cb2d305228691d6ae4ecb6 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-04 | 182 | 87 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.44e-04 | 182 | 87 | 4 | fec1caf867b1dc87b24504d895ee1a27df78062e | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 4.53e-04 | 183 | 87 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 4.53e-04 | 183 | 87 | 4 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 4.53e-04 | 183 | 87 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.53e-04 | 183 | 87 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 4.72e-04 | 185 | 87 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.82e-04 | 186 | 87 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 186 | 87 | 4 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.82e-04 | 186 | 87 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-04 | 186 | 87 | 4 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 4.82e-04 | 186 | 87 | 4 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 187 | 87 | 4 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-04 | 187 | 87 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 4.91e-04 | 187 | 87 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-04 | 187 | 87 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-04 | 187 | 87 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-04 | 187 | 87 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 187 | 87 | 4 | f4de4b7af1fdfbd628b1f509c060c1079d2e5437 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 187 | 87 | 4 | 81754e965848b718be20ee97ce072ce426938a69 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.11e-08 | 173 | 87 | 9 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.98e-08 | 180 | 87 | 9 | 1793_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.53e-07 | 167 | 87 | 8 | 3979_DN | |
| Drug | Clidinium bromide [3485-62-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.22e-07 | 195 | 87 | 8 | 3476_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 9.58e-07 | 199 | 87 | 8 | 1660_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.45e-06 | 166 | 87 | 7 | 2247_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.45e-06 | 166 | 87 | 7 | 2268_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.37e-06 | 172 | 87 | 7 | 2330_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.28e-06 | 177 | 87 | 7 | 873_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.47e-06 | 178 | 87 | 7 | 7245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.57e-06 | 183 | 87 | 7 | 7136_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.81e-06 | 184 | 87 | 7 | 7555_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 3549_DN | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 5292_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; HL60; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 3112_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A | 1.06e-05 | 197 | 87 | 7 | 3076_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.10e-05 | 198 | 87 | 7 | 2256_DN | |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A | 1.17e-05 | 200 | 87 | 7 | 1953_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.84e-05 | 163 | 87 | 6 | 7453_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.84e-05 | 163 | 87 | 6 | 7285_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.98e-05 | 164 | 87 | 6 | 4388_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.11e-05 | 165 | 87 | 6 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.25e-05 | 166 | 87 | 6 | 7324_DN | |
| Drug | 2-methyl-2,2'-bioxirane | 4.32e-05 | 3 | 87 | 2 | CID000022811 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.55e-05 | 168 | 87 | 6 | 3395_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.86e-05 | 170 | 87 | 6 | 1050_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.19e-05 | 172 | 87 | 6 | 6439_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.19e-05 | 172 | 87 | 6 | 1072_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.19e-05 | 172 | 87 | 6 | 5903_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.36e-05 | 173 | 87 | 6 | 4458_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.53e-05 | 174 | 87 | 6 | 7105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.71e-05 | 175 | 87 | 6 | 3787_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 5.89e-05 | 176 | 87 | 6 | 7499_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.89e-05 | 176 | 87 | 6 | 981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.08e-05 | 177 | 87 | 6 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.08e-05 | 177 | 87 | 6 | 3227_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.27e-05 | 178 | 87 | 6 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.47e-05 | 179 | 87 | 6 | 4483_DN | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 6.67e-05 | 180 | 87 | 6 | 5027_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.67e-05 | 180 | 87 | 6 | 5511_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.88e-05 | 181 | 87 | 6 | 7077_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 7.10e-05 | 182 | 87 | 6 | 3887_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.00e-05 | 186 | 87 | 6 | 6874_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.24e-05 | 187 | 87 | 6 | 6671_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 8.49e-05 | 188 | 87 | 6 | 6451_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.00e-05 | 190 | 87 | 6 | 5602_UP | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 4848_DN | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 194 | 87 | 6 | 2831_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 5447_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 7309_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.04e-04 | 195 | 87 | 6 | 6661_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 1686_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 3872_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 1.07e-04 | 196 | 87 | 6 | 6745_DN | |
| Drug | Sulpiride [15676-16-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 1467_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 6204_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; HL60; HG-U133A | 1.10e-04 | 197 | 87 | 6 | 1578_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 4501_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 197 | 87 | 6 | 3314_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3332_DN | |
| Drug | (+,-)-Octopamine hydrochloride [770-05-8]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 5469_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 4729_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3869_DN | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.13e-04 | 198 | 87 | 6 | 3880_DN | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 7414_UP | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 5093_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 1648_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 87 | 6 | 3346_DN | |
| Drug | CP 154526 | 1.43e-04 | 5 | 87 | 2 | ctd:C101628 | |
| Drug | 2-methyl-3-phenylpropionamide | 1.97e-04 | 75 | 87 | 4 | CID000348285 | |
| Disease | alcohol consumption measurement | C4orf17 MAGI1 TINAG TRAF5 ZZZ3 NF1 KIF26A COBLL1 MACROD2 NPAS3 CLIC6 MGA ECE2 | 5.39e-05 | 1242 | 85 | 13 | EFO_0007878 |
| Disease | Self-injurious behavior | 7.78e-05 | 78 | 85 | 4 | HP_0100716 | |
| Disease | 1,5 anhydroglucitol measurement | 7.99e-05 | 29 | 85 | 3 | EFO_0008009 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 8.15e-05 | 5 | 85 | 2 | C3281201 | |
| Disease | post-traumatic stress disorder symptom measurement | 9.45e-05 | 82 | 85 | 4 | EFO_0008535 | |
| Disease | 3-ureidopropionate measurement | 1.22e-04 | 6 | 85 | 2 | EFO_0010641 | |
| Disease | Constipation | 1.71e-04 | 7 | 85 | 2 | C0009806 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.56e-04 | 195 | 85 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | post-traumatic stress disorder | 3.01e-04 | 202 | 85 | 5 | EFO_0001358 | |
| Disease | Heart Diseases | 3.20e-04 | 46 | 85 | 3 | C0018799 | |
| Disease | sexual dimorphism measurement | 3.29e-04 | 1106 | 85 | 11 | EFO_0021796 | |
| Disease | Neuroblastoma | 3.41e-04 | 47 | 85 | 3 | C0027819 | |
| Disease | neuroblastoma (is_implicated_in) | 3.64e-04 | 10 | 85 | 2 | DOID:769 (is_implicated_in) | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 3.86e-04 | 49 | 85 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | neutrophil count | HIVEP3 MAGI1 HIVEP2 DSCAM MYCBP2 ZNF398 PCDHA7 PCDHA4 PCDHA1 ARID1A MAP3K5 EHD4 | 5.90e-04 | 1382 | 85 | 12 | EFO_0004833 |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 6.27e-04 | 13 | 85 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome | 6.27e-04 | 13 | 85 | 2 | C0265338 | |
| Disease | Abnormality of refraction | 7.23e-04 | 673 | 85 | 8 | HP_0000539 | |
| Disease | Metabolic Bone Disorder | 7.30e-04 | 14 | 85 | 2 | C0005944 | |
| Disease | triglycerides in small VLDL measurement | 7.36e-04 | 61 | 85 | 3 | EFO_0022145 | |
| Disease | phospholipids in large VLDL measurement | 7.72e-04 | 62 | 85 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 7.72e-04 | 62 | 85 | 3 | EFO_0022322 | |
| Disease | Waxy flexibility | 8.40e-04 | 15 | 85 | 2 | C0233612 | |
| Disease | Catalepsy | 8.40e-04 | 15 | 85 | 2 | C0007370 | |
| Disease | Osteopenia | 8.40e-04 | 15 | 85 | 2 | C0029453 | |
| Disease | Drugs used in diabetes use measurement | 8.66e-04 | 255 | 85 | 5 | EFO_0009924 | |
| Disease | triglycerides in small LDL measurement | 8.86e-04 | 65 | 85 | 3 | EFO_0022323 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 8.98e-04 | 148 | 85 | 4 | C0279702 | |
| Disease | T-Cell Lymphoma | 9.59e-04 | 16 | 85 | 2 | C0079772 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 9.59e-04 | 16 | 85 | 2 | C1257877 | |
| Disease | Moyamoya Disease | 1.08e-03 | 17 | 85 | 2 | C0026654 | |
| Disease | Pheochromocytoma | 1.36e-03 | 19 | 85 | 2 | C0031511 | |
| Disease | non-alcoholic fatty liver disease | 1.92e-03 | 182 | 85 | 4 | EFO_0003095 | |
| Disease | Huntington's disease (is_implicated_in) | 1.99e-03 | 23 | 85 | 2 | DOID:12858 (is_implicated_in) | |
| Disease | feeling nervous measurement | 2.05e-03 | 87 | 85 | 3 | EFO_0009597 | |
| Disease | visceral adipose tissue measurement, body mass index | 2.05e-03 | 87 | 85 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | urate measurement, bone density | 2.08e-03 | 619 | 85 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | Hypermetropia, Myopia | 2.20e-03 | 189 | 85 | 4 | HP_0000540, HP_0000545 | |
| Disease | Brain Diseases | 2.36e-03 | 25 | 85 | 2 | C0006111 | |
| Disease | refractive error, age at onset, Myopia | 2.38e-03 | 193 | 85 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Parkinson disease | 2.38e-03 | 321 | 85 | 5 | MONDO_0005180 | |
| Disease | unipolar depression | KIAA1671 TBC1D16 BPTF HIVEP2 ATXN7L2 PCDHA4 ABT1 PCDHA1 MAP3K5 ITPKB | 2.43e-03 | 1206 | 85 | 10 | EFO_0003761 |
| Disease | Neurodevelopmental Disorders | 2.48e-03 | 93 | 85 | 3 | C1535926 | |
| Disease | Bipolar Disorder | 2.58e-03 | 477 | 85 | 6 | C0005586 | |
| Disease | eye measurement | 2.75e-03 | 27 | 85 | 2 | EFO_0004731 | |
| Disease | glucose tolerance test | 2.75e-03 | 27 | 85 | 2 | EFO_0004307 | |
| Disease | Encephalopathies | 2.75e-03 | 27 | 85 | 2 | C0085584 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGSILSPSEKETPPG | 546 | Q8N1M1 | |
| GPGPVSTPDNRKEMA | 551 | O75150 | |
| NKRAAGEPGTSMPPE | 6 | Q5VTR2 | |
| READGTGSPSPAPMR | 1361 | A6NC98 | |
| APGPATPMLFEKDGS | 821 | Q2NKJ3 | |
| ISRSPSGPPAMDLEG | 6 | O96018 | |
| PFGGMRKVPGSSEPF | 1351 | Q8NFD5 | |
| MPGFPDNIRPSSSGG | 301 | Q9HDC9 | |
| RPPGKEATPGEMVSA | 296 | Q9Y4F5 | |
| LAPGTNPPFMTFDGE | 521 | Q96NY7 | |
| DMAAKAPPGGGTTRT | 1921 | Q12830 | |
| APKMTRDTGTAPFAP | 826 | Q53SF7 | |
| PFPMPRGGTQASSEE | 371 | Q5T6C5 | |
| QSAGKSGRRPMPGPS | 1366 | Q9P241 | |
| GALRGSPPFEMLSPS | 31 | P13631 | |
| SPPFEMLSPSFRGLG | 36 | P13631 | |
| SGEMPPASPSFPRNK | 601 | Q96JM7 | |
| SSSMAEGGDLKPPTP | 1151 | O14497 | |
| DPYGSMRKAPGSDPF | 1231 | O14497 | |
| DPGRFSKVSSPAPME | 1746 | O14497 | |
| SGPFSFSVIDKPPGM | 526 | Q14126 | |
| GEGPPKTDLMAFSPS | 761 | Q9UN72 | |
| DDFRMPNGSTIPPGS | 4846 | Q99102 | |
| PMSPSPASGLSKGER | 806 | Q96QZ7 | |
| SQGFTPPGMDRSSPD | 966 | Q12791 | |
| RPVPKLSPEMGSFGS | 671 | Q9NS87 | |
| KPEMGSPRALVGGSS | 361 | Q9BY89 | |
| PPFGGSRTPSTSDMA | 1286 | Q9HCH0 | |
| TPDGPLSPGKMEDIS | 1416 | Q8IWI9 | |
| FSDLEKSPSPTPVMG | 371 | Q86W92 | |
| SESPTFSPGKMGPRA | 1486 | Q9UPA5 | |
| PSFRRKMGTEGSEPG | 1126 | Q8ND23 | |
| MEVGKGASPFSPGPS | 41 | P0DPD6 | |
| AECAPGSGPMFKPTT | 206 | Q9UKJ3 | |
| PMASPGGSIDERPLS | 276 | Q00613 | |
| KPDLSAETPMFPGNG | 51 | P01189 | |
| PEAASPRKAVGTPMA | 881 | Q9ULI4 | |
| FPGMRIGPEPTTDSF | 86 | Q9H223 | |
| PGPNPSTMDSGSGDK | 201 | Q96A73 | |
| AGMSSEDDGLPRSPP | 151 | Q6NV74 | |
| PAPSPTRGFGKMFVS | 116 | Q7Z309 | |
| SEGPPKTDLMAFSPG | 761 | Q9Y5I3 | |
| RPPGTSDLGFPLDMT | 176 | Q9HBE1 | |
| SMPEGPFPGRLVDVS | 726 | Q9NRJ7 | |
| GEGPPKTDLMAFSPS | 761 | Q9UN74 | |
| FEDTGGPTRKMPPSA | 106 | Q8N414 | |
| GPTRKMPPSASAVDF | 111 | Q8N414 | |
| ARIFGAPPPSESMEG | 251 | Q9ULW3 | |
| ESPVRGMSPAPNGAK | 91 | Q53FE4 | |
| EMDGPEGSTKPIRSP | 291 | Q7Z4T8 | |
| EGSTKPIRSPAMSGG | 296 | Q7Z4T8 | |
| MAPIPGSKRFSPAGL | 1311 | Q5VT06 | |
| NEPKRPMSGEYGPAS | 271 | Q9Y6X4 | |
| GPPPSAIRDMGIKST | 151 | Q96RQ3 | |
| SGKRDPGPSGKADPM | 286 | Q7Z2K8 | |
| KMDPASSGEGRPVSG | 376 | Q7Z2K8 | |
| SDPLFIGGPRPTMAK | 366 | Q8NEC7 | |
| SKPRIGSEDASPMGP | 1056 | Q9C0B2 | |
| ASGGPPVSKAPTMDA | 501 | A6NNC1 | |
| PPSPEEKDSGFFMLR | 1031 | Q99683 | |
| PGEDTPRMPGKSEGS | 386 | A1Z1Q3 | |
| PKFRSPSDEGPGSMG | 401 | Q92918 | |
| FTASPPKPQDGGRVM | 1871 | O60469 | |
| MSYGRPPPDVEGMTS | 1 | Q01130 | |
| IPFRPKSGDGPMTAS | 686 | Q9GZN6 | |
| SFTGKGGPPLAMASE | 486 | Q15031 | |
| MDRLGPFSNDPSDKP | 1 | O75478 | |
| GGSGMKAPETEPFLR | 276 | O95255 | |
| GPAPGSKPVQFMDFE | 31 | Q8WUX1 | |
| PPKPSSAGEMSPQRF | 1001 | A1L390 | |
| PSAFVRMEKGIPASP | 251 | P27987 | |
| PDLGSDYKPPMSGSN | 1076 | Q92859 | |
| GPGPASARPSESKEM | 436 | Q96NU1 | |
| PPDTNSMELGGRPTF | 456 | Q9UPS6 | |
| DGRMPSSSRAESPGP | 2801 | O75592 | |
| VNSPGFGLDPKTPME | 856 | Q8IXF0 | |
| MREPPGQTTKEPFGG | 376 | O95785 | |
| LSSGPSMPFIKEGDG | 951 | Q9UHV7 | |
| PDPNSSSFKRPDGEM | 501 | O00463 | |
| KMGPDSKPSEGDVFP | 631 | Q9BY15 | |
| SQPRKESMGPPGLES | 431 | Q86T13 | |
| MTPFGRPATDLPEAS | 306 | Q8TD17 | |
| PYGGTVEMPSPKSLR | 736 | Q8TBP0 | |
| LVDPMRPGPSGSFVA | 121 | Q5T1R4 | |
| ATYSPPMGPVSERKG | 861 | P21359 | |
| SPYGTLKPEEMSGPG | 1691 | Q5JSZ5 | |
| MAAPSDGFKPRERSG | 1 | Q92979 | |
| DPGTPETGRSGATKM | 2351 | Q96JG9 | |
| SCLFAMPPEVKGPSG | 361 | Q6P2C0 | |
| MAENGESSGPPRPSR | 1 | Q9UHD9 | |
| DGFKFRLGTLPPSPM | 186 | Q9UJW2 | |
| SLFAEASDKMSPGPP | 286 | P31629 | |
| MLPLSDGPEGSSSRP | 621 | Q8IYH5 | |
| MPTPDATTPQAKGFR | 1 | P07101 |